辉瑞参加 AWS re:Invent 2023

United Arab Emirate’s (UAE) Technology Innovation Institute (TII), the applied research pillar of Abu Dhabi’s Advanced Technology Research Council, has launched Falcon LLM, a foundational large language model (LLM) with 40 billion parameters. TII is a leading global research center dedicated to pushing the frontiers of knowledge.

At re:Invent 2023, Marc Berson, Chief Information Officer of Gilead Sciences, joined an Innovation Talk on ‘Generative AI for Industries’, along with Shaown Nandi, AWS Director of Technology for Industries. The talk highlighted Gilead’s approach towards using generative AI for accelerating therapeutic breakthroughs, and emphasized their commitment to establishing a resilient cloud infrastructure and solid data foundations, to enable the technology at an enterprise level.

Merck & Co., Inc., Rahway, NJ, USA, one of the largest pharmaceutical companies in the world, has been using generative artificial intelligence (generative AI) to push the borders of data science and analytics in life sciences. Harish Nankani, Associate Vice President, Data and Analytics, Merck, and Suman Giri, Executive Director, Data Science, Merck, recently spoke to Ujjwal Ratan, Data Science and ML Leader for Healthcare and Life Sciences at AWS, on the promise and potential of this groundbreaking technology for commercial teams in life sciences organizations

Imagine a future where life-saving drugs are developed not in years but in months, where personalized medicines are crafted with precision, and where global health crises find their match in the swift, intelligent responses of advanced systems. This is not a work of fiction; this is the reality that Sanofi is bringing to life on Amazon Web Services (AWS).